Table 1.

Baseline characteristics of 441 HIV-infected women initiating ART by HCV status, Women's Interagency HIV Study, January 2000-September 2015.

	HCV+ (n=114)		HCV- (n=327)		Total (n=441)
	Median or n	IQR^a or %	Median or n	IQR^a or %	Median or n	IQR^a or %
Age at ART initiation (years)	47	42, 51	41	36, 47	43	37, 49
Race/ethnicity
White, non-Hispanic	18	16%	36	11%	54	12%
Black, non-Hispanic	77	68%	217	66%	294	67%
Other ^b	19	17%	74	23%	93	21%
Education ^c
Less than high school	48	42%	103	32%	151	34%
Graduated high school	29	25%	109	33%	138	31%
Some college	37	32%	114	35%	151	34%
Annual household income <$12,000	85	77%	163	51%	248	56%
Alcohol use ^d
0 drinks per week	60	53%	150	46%	210	48%
1 – 7 drinks per week	32	28%	135	41%	167	38%
>7 drinks per week	22	19%	42	13%	64	15%
Ever used non-injection drugs	109	96%	221	68%	330	75%
Ever injected drugs	99	87%	35	11%	134	30%
Chronic active HBV ^e	1	<1%	8	2%	9	2%
Year of ART initiation ^f
2000–2005	80	70%	161	49%	241	55%
2006–2010	28	25%	70	21%	98	22%
2011–2015	6	5%	96	30%	102	23%
Single or dual antiretroviral use ^g	57	50%	92	28%	149	34%
CD4 cell count at baseline	287.5	172, 392	313	194, 454	303	188, 440
HIV viral load at baseline ^h	4.16	3.11, 4.84	4.23	3.34, 4.77	4.20	3.27 4.79
FIB-4 > 1.45	91	80%	70	21%	161	37%

^a Interquartile range

^b Other race/ethnicity includes Hispanic, Native American/Alaskan Native, Asian/Pacific Islander, and races/ethnicities categorized as other.

^c Education categories do not add to the total due to missing information

^d Self-reported alcohol use within the last six months

^e Chronic, active hepatitis B infection is defined as positive hepatitis B core antibody and positive hepatitis B surface antigen, and measured during one of the first three study visits after enrollment.

^f ART is defined as use of three or more antiretroviral medications approved by contemporaneous DHHS guidelines

^g Self-reported use of single or dual antiretroviral prior to ART initiation.

^h HIV viral load is reported in log₁₀ copies/mL.